One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says

A widely used anxiety medication is being pulled from shelves due to "failed dissolution specifications," the U.S. Food and Drug Administration (FDA) said.

The agency's enforcement report said that one lot of Xanax has been recalled nationwide by the company Viatris.

The recall, issued March 17, affects lot number 8177156. The bottle...

Rising ACA Costs Leave Many Unable To Pay for Coverage

Higher health insurance costs are forcing some people to walk away from coverage even after signing up.

About 14% of people who enrolled in Affordable Care Act (ACA) plans for 2026 did not pay their first monthly premium, according to a new analysis from Wakely Consulting Group, an actuarial firm.

That’s much higher than the us...

Cough Drops From Several Brands Being Recalled, FDA Says

Several common cough drop brands are being pulled from shelves after officials raised concerns about how they were made.

The U.S. Food and Drug Administration (FDA) said a China-based company, Xiamen Kang Zhongyuan Biotechnology Co., Ltd, issued a recall that includes 15 products.

The recall began March 20 and includes cough drops so...

CDC May Get New Leader as Officials Consider Erica Schwartz

Federal health officials are considering Dr. Erica Schwartz to lead the U.S. Centers for Disease Control and Prevention (CDC), according to people familiar with the discussions.

The decision is not yet final and would still need approval from President Donald Trump. It’s also not clear whether the administration will move forward wit...

New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes

New anti-amyloid drugs approved to treat Alzheimer’s disease have no clinically meaningful positive effects for patients, a major evidence review has concluded.

Drugs like Leqembi (lecanemab) and Kinsula (donanemab) have little to no effect on patients’ cognitive decline and dementia, according to results published by the C...